Thirdly, Although some scholars have proposed initial ideas to target SLC7A11 for cancer treatment, such as directly inhibiting the activity of SLC7A11 transport protein, or starting from the metabolic vulnerability of cancer and SLC7A11. Here, SLC7A11 is linked to cancer.